Novel approaches to a sustainable industrial «white» biotechnology
Jörg Riesmeier is an executive with a proven track record in industrial biotechnology, both in long-range industry investment and in product development. He will be leading the company together with the company’s CEO, Dr. Thomas von Rüden.
Source & Further Information
Press Release DIREVO, January 18, 2010.
DIREVO Industrial Biotechnology GmbH is Partner of BIOCATALYSIS2021
Source & Further Information
Press Release DIREVO, January 18, 2010.
DIREVO Industrial Biotechnology GmbH is Partner of BIOCATALYSIS2021
BIOCATALYSIS2021 News in German RSS
The Cluster BIOCATALYSIS2021 coordinates the unique expert knowledge of 15 large companies, 18 small and medium-sized companies, as well as of 22 academic research groups and 7 agencies promoting innovations and economy.
BIOCATALYSIS2021 is open for further partners and projects. Applications are welcome. 
Euro Biotech News
Addex reports on new Alzheimer compound
Geneva - Allosteric modulation specialist Addex Pharmaceuticals Ltd has observed efficacy of its oral pre-clincal drug...
Dutch researchers crack cancer chemotherapy resistance mechanism
Groningen Researchers from the University of Groningen have identified a new mechanism that enables cancer cells to...
Researchers unravel genes behind Mabry Syndrome
Most rare diseases are hereditary but their exact cause often remains unclear. Researchers at the Max Planck used Next...
Biocrates and Selexis SA enter drug manufacturing collaboration
Innsbruck/Plan-les-Ouates Austrian metabolic biomarker expert Biocrates Life Sciences AG, and Swiss biomanufacturing...
Genetic link reveals that glutamate plays an important role in common migraine
Leiden/Hinxton - UK and Dutch researchers have found the first-ever genetic risk factor associated with common types...